Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome.
A 6-year-old male being treated with limited efficacy by methylphenidate immediate release for attention-deficit hyperactivity disorder also presented with sleep disruption due to potential restless legs/periodic limb movement syndrome. Treatment with the dopamine agonist ropinirole resulted in a significant improvement in both his attention-deficit hyperactivity disorder symptoms and sleep problems.
Konofal
Eric
E
Service de Psychopathologie de l'Enfant et de l'Adolescent, Hôpital Robert Debré, Paris, France.
Arnulf
Isabelle
I
Lecendreux
Michel
M
Mouren
Marie-Christine
MC
D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000188:drug therapy*; D002648:Child; D018491:Dopamine Agonists / Q000008:administration & dosage*; D006801:Humans; D007211:Indoles / Q000008:administration & dosage*; D008297:Male; D012148:Restless Legs Syndrome / Q000150:complications / Q000188:drug therapy*
D018491:Dopamine Agonists; D007211:Indoles; C046649:ropinirole